Author | David Morris, MD, FACS | OncLive

Author | David Morris, MD, FACS

Articles

Dr. Morris on OS Data With Apalutamide in Prostate Cancer

April 15, 2020

Video

David Morris, MD, FACS, discusses overall survival data with apalutamide in prostate cancer.

Dr. Morris on Treatment Considerations for CRPC

February 05, 2020

Video

David Morris, MD, FACS, discusses choosing the best agent to treat patients with nonmetastatic castration-resistant prostate cancer.

Dr. Morris on Safety Profiles of AR Inhibitors in Prostate Cancer

November 27, 2019

Video

David Morris, MD, FACS, discusses the safety profiles and common adverse events related to the androgen receptor inhibitors apalutamide, enzalutamide, and darolutamide for prostate cancer.

x